Why it matters:
Aflac Inc., a major supplemental insurance provider, reveals significant spending to influence healthcare, tax, and benefits legislation. These are areas directly impacting its business model and the broader insurance industry.

By the numbers:

  • Aflac’s lobbying expenditure shows an upward trend, reaching $1.7 million in Q4 2024, a 13.85% increase from the previous quarter.
  • The company maintains a substantial in-house lobbying operation ($1.5 million in Q4 2024) supplemented by six external firms.

The issues:
Aflac’s Q1 2025 filing reveals four key lobbying priorities:

  • Paid family medical leave policies
  • National defense program appropriations
  • Healthcare and insurance regulation, particularly regarding the Affordable Care Act and excepted benefits
  • Tax treatment of fixed indemnity plans and insurance benefits

Who’s doing the lobbying:
Aflac deploys a strategic mix of veteran lobbyists and those with recent government experience:

  • Gina Joy Rigby-House has represented Aflac since 2001, bringing over two decades of institutional knowledge
  • Bradley Lamont Knox, active since 2006, leverages his experience as Chief Tax Counsel for the House Small Business Committee
  • Chasseny M. Lewis brings fresh connections from her time with the House Financial Services Committee
  • Sydney Shea Fincher contributes Senate expertise from her work with the Senate Judiciary Committee
  • Kenneth Summers appears to be a new addition to the team

External muscle: While the Q1 2025 filing details in-house activities, Aflac’s recent history shows strategic use of specialized firms:

Between the lines:
Aflac’s lobbying strategy reflects defensive and opportunistic positioning including:

  1. The company’s focus on preserving the regulatory framework for excepted benefits and fixed indemnity plans is crucial to its business model;
  2. Attention to paid family leave signals preparation for potential federal mandates that could reshape the voluntary benefits market, and
  3. Interest in defense appropriations suggests targeting opportunities with military personnel and government employees.

The big picture:
Aflac’s consistent investment in lobbying indicates active policy battles that affect multiple players in the supplemental health insurance space.

What to watch:
The significant increase in Aflac’s lobbying expenditures heading into 2025 suggests the company anticipates critical policy developments affecting its business interests.